Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine

The Journal of Neuropsychiatry and Clinical Neurosciences
Philip D HarveyAntony Loebel

Abstract

The authors examined cognitive changes associated with treatment with ziprasidone and olanzapine over a 6-month double-blind clinical trial, using normative standards for the cognitive measures. Sixty-two schizophrenia patients entered the study on ziprasidone treatment (39 completers), and 71 patients entered while receiving treatment with olanzapine (33 completers). From a larger set of cognitive domains assessed in the acute treatment study, we selected verbal learning, executive functioning, and verbal fluency for further analysis due to their functional relevance and extensive normative data. Standard scores were developed based on previously published age- and education-corrected norms. Baseline performance was impaired across all tests on average. The proportion of patients impaired on each of the tests at baseline ranged from 36% (letter fluency) to 89%. Performance was significantly improved by ziprasidone and olanzapine treatment for all cognitive variables and for the composite measure. A number of subjects met the a priori criteria for normalization in performance, ranging from 10% for Trail Making Test Part B to 37% for Word List Total Learning. There were no significant differences across medications in extent of ...Continue Reading

Citations

Jul 1, 2006·Psychopharmacology·Robert S KernRon Marcus
Mar 8, 2007·Expert Review of Neurotherapeutics·Christopher R Bowie, Kushik Jaga
Jan 29, 2008·Psychiatry Research·Hiroaki HoriHiroshi Kunugi
Dec 6, 2011·International Journal of Psychiatry in Clinical Practice·Hikaru HoriJun Nakamura
Mar 6, 2009·Journal of Neurology·Roberto CavalloSimone Baldovino
Feb 14, 2016·Neuropsychological Rehabilitation·Antonio VitaEmilio Sacchetti
Nov 16, 2007·Journal of Geriatric Psychiatry and Neurology·John O Brooks, Jennifer C Hoblyn
Dec 14, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·E JohnsenE-M Løberg
Oct 16, 2007·CNS Spectrums·Timothy J OsterDavid B Arciniegas
Apr 5, 2021·Neuroscience and Biobehavioral Reviews·Daniel Prates BaldezLetícia Sanguinetti Czepielewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here